Health and Medication Training: Developing a Comprehensive Development Plan

The Program Capacity Building, led by the University Innovation Hub at the University of Montpellier, offers targeted training in innovation and research commercialization. Through thematic modules led by experts, it supports the professional development of professionals involved in innovative projects.

On May 7, a training session will focus on developing a comprehensive development plan for a drug. It is intended for staff involved in therapeutic projects (small molecules, antibodies, gene therapies) who wish to build a robust roadmap aligned with the requirements of health regulatory agencies.

This session will cover the following topics:

• the key stages of preclinical and clinical development (Phases I, II, and III);
• regulatory procedures (marketing authorization, temporary use authorization);
• technology readiness levels (TRL);
• interactions with regulatory agencies (ANSM, EMA, FDA);
• public funding programs (i-Lab, Horizon Europe);
• the definition of milestones and deliverables.

Are you interested in this training course? Let us know by emailing please specify your position and department.

To explore all the modules offered by the program, please consult the complete Capacity Building course catalog.